Positive correlations between CRP and TGL serum levels were reported: (a) in patients with dyslipidemia and increased risk for atherosclerosis [74]; (b) in patients with accelerated progression of Alzheimer’s disease [75]; (c) in patients with type 2 diabetes mellitus and dyslipidemia [76], the common denominator being, in such patients, the systemic inflammatory state. This evidence concerns the gene CRP and diabetes mellitus.